BioPharma Credit PLC (BPCR) Fair Value & Analysis

Financial Services · GB · Market cap $108B

Price$0.0095

Fair Value$0.0200

Upside+110.5%

Quality95/100

Evidence: High Range $0.0100 – $0.0200

Analysis

BioPharma Credit PLC (BPCR) currently trades at $0.0095, while our model-based Fair Value estimate is $0.0200 — implying the stock looks roughly 110.5% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Open the full interactive analysis →

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.